{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:48:55Z","timestamp":1792680535301,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2014ZX10003003"],"award-info":[{"award-number":["2014ZX10003003"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2017ZX10201302-003"],"award-info":[{"award-number":["2017ZX10201302-003"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.eclinm.2026.103831","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:09:45Z","timestamp":1773446985000},"page":"103831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-4616","authenticated-orcid":false,"given":"Lifan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cainan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baotong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiren","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7990-9003","authenticated-orcid":false,"given":"Yuelun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.103831_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103831_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103831_bib3","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1080\/22221751.2021.2004864","article-title":"Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China","volume":"10","author":"Liu","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.eclinm.2026.103831_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/annrheumdis-2019-216128","article-title":"Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO)","volume":"79","author":"Pettipher","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.eclinm.2026.103831_bib5","first-page":"6603","article-title":"The clinical characteristics of 11 systemic lupus erythematosus patients with central nervous system tuberculosis infection","volume":"5","author":"Yang","year":"2011","journal-title":"Chin J Clin (Electronic Edition)"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103831_bib6","first-page":"599","article-title":"Literature review and analysis of tuberculosis infection complicating systemic lupus erythematosus in China","volume":"13","author":"Wang","year":"2009","journal-title":"Chin J Rheumatol"},{"issue":"9","key":"10.1016\/j.eclinm.2026.103831_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(23)00096-6","article-title":"Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis","volume":"11","author":"Winters","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eclinm.2026.103831_bib8","series-title":"Guidelines on the Management of Latent Tuberculosis Infection","year":"2015"},{"issue":"23","key":"10.1016\/j.eclinm.2026.103831_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103831_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"10","key":"10.1016\/j.eclinm.2026.103831_bib11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","article-title":"Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103831_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cmi.2020.06.008","article-title":"Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial","volume":"27","author":"Ruan","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.eclinm.2026.103831_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01470-2018","article-title":"Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study","volume":"52","author":"Gao","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.eclinm.2026.103831_bib14","first-page":"228","article-title":"A study of pharmacokinetic of rifapentine combined with isoniazid in the preventive treatment of tuberculosis in silicotic patients","volume":"43","author":"Yang","year":"2021","journal-title":"Chin J Antituberc"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103831_bib15","first-page":"421","article-title":"Guidelines for the Chemotherapy of Drug-Resistant Tuberculosis (2015)","volume":"37","year":"2015","journal-title":"Chin J Antituberc"},{"key":"10.1016\/j.eclinm.2026.103831_bib16","series-title":"Technical Specifications for Tuberculosis Prevention and Control in China (2020 Edition)","year":"2020"},{"key":"10.1016\/j.eclinm.2026.103831_bib17","article-title":"Latent Tuberculosis infection and associated factors in patients with systemic lupus erythematosus: a multicenter, cross-sectional Study","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.eclinm.2026.103831_bib18","article-title":"Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.eclinm.2026.103831_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103177","article-title":"Effectiveness of tuberculosis preventive treatment in patients with rheumatic diseases: a global systematic review and meta-analysis","volume":"82","author":"Wang","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"17","key":"10.1016\/j.eclinm.2026.103831_bib20","first-page":"1303","article-title":"[Practice guidelines for diagnosis, treatment, and prevention of tuberculosis in patients with rheumatic disease (2025 edition)]","volume":"105","year":"2025","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.eclinm.2026.103831_bib21","series-title":"Analysis of Risk Factors for Reactivation of Latent Tuberculosis Infection and Evaluation of the Efficacy of Tuberculosis Preventive Treatment in Patients with Rheumatic Diseases; [Master's thesis]","author":"Zheng","year":"2018"},{"issue":"22","key":"10.1016\/j.eclinm.2026.103831_bib22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103831_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of latent tuberculosis infection: an updated network meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103831_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2026.103831_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/rheumatology\/key364","article-title":"Risk of tuberculosis in patients with immune-mediated diseases on biological therapies: a population-based study in a tuberculosis endemic region","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.eclinm.2026.103831_bib26","series-title":"WHO Onsolidated Guidelines on Tuberculosis: Module 1: Prevention-Tuberculosis Preventive Treatment, Second Edition. Second Edition Geneva: World Health Organization; 2024 Licence: CC BY-NC-SA 30 IGO","year":"2024"},{"issue":"4 Pt 2","key":"10.1016\/j.eclinm.2026.103831_bib27","first-page":"S221","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.103831_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/joim.13218","article-title":"Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study","volume":"290","author":"Xiao","year":"2021","journal-title":"J Intern Med"},{"issue":"23","key":"10.1016\/j.eclinm.2026.103831_bib29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.103831_bib30","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.2147\/IDR.S471448","article-title":"Knowledge and attitudes about screening and preventive treatment of latent tuberculosis infection among patients with rheumatic diseases in Beijing, China","volume":"17","author":"Xie","year":"2024","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.eclinm.2026.103831_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5588\/ijtld.21.0667","article-title":"WHO target product profiles for TB preventive treatment","volume":"26","author":"Den Boon","year":"2022","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:07:53Z","timestamp":1778904473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S2589537026000787"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103831","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.103831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103831"}}